echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Eighteen injections and one inhaler were newly announced.

    Eighteen injections and one inhaler were newly announced.

    • Last Update: 2020-08-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On 5 August, CDE published the Chemical Generics Participating Preparations Catalog (32nd Batch), covering a total of 65 varieties (in the name of the drug), 18 of which were injections and 1 was inhalers.
    2019, three injections will have terminal sales of more than 2 billion yuan in China's public medical institutions, according to data from the 100-meter intranet.
    In CDE's newly announced list of relevant preparations, covering a number of large varieties of heavy injections, including volicazole for injection, potassium amoxicillin for injection, tyrone for injection, etc., in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township health hospitals (referred to as China's public medical institutions) terminal sales of more than 2 billion yuan.
    Figure 1: Injection Voliconazole consistency evaluation declaration of the rice net data show that the injection of Voliconazole has not been evaluated by enterprises, 6 enterprises have laid out the product consistency evaluation, including Qilu, Yangzijiang, Hainan, etc.
    6 enterprises are reported in the new classification, after the approval of production will be treated as through consistency evaluation.
    Figure 2: Injection with tyrone consistency evaluation declaration of injection with tyrone has not yet been evaluated by enterprises, 6 enterprises have laid out the product consistency evaluation, including Osecon, Zheng Datianqing, Howson and so on.
    Jianyou Biochemicals in Nanjing with a new classification, the remaining five enterprises have submitted a consistency evaluation supplementary application.
    aerosols are the only inhalants in this catalog that can relieve asthma symptoms and allergic rhinitis by inhaling aerosols.
    no domestic products have been evaluated, four Trump Sharp Pharmaceuticals exclusive to copy 3 categories of declared clinical, and in October 2017 was approved clinical.
    : Chemical generics referral preparation catalog (32nd batch) (draft for comments) Source: In-network database, CDE Note: data statistics as of August 6, if there are omissions, welcome to point the right!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.